Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the National Cancer Institute|July 19, 1989
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell lineH Timmer-Bosscha, G A Hospers, C Meijer, et al.
Gene Therapy|November 13, 2001
Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccinesS Withoff, K L Glazenburg, M L van Veen, et al.
Cancer Research|May 27, 1999
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrierN H Hendrikse, E G de Vries, L Eriks-Fluks, et al.
Cancer Research|December 1, 1988
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitroG A Hospers, N H Mulder, B de Jong, et al.
Anticancer Research|July 1, 1995
Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancerN H Mulder, W V Dolsma, P O Mulder, et al.
Bone Marrow Transplantation|July 4, 2001
Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumoursP Nieboer, E G de Vries, N H Mulder, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Molecular imaging of breast cancerT H Oude Munnink, W B Nagengast, A H Brouwers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancerT H van Dijk, K Tamas, J C Beukema, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 20, 2023
Health-state utilities in long-term advanced melanoma survivors comparable with the general populationM D Egeler, L V van de Poll-Franse, R Tissier, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2020
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controlsA H Boekhout, A Rogiers, K Jozwiak, et al.
Pageof 3